WO2005107498A1 - ポリフェノールを含有する食品 - Google Patents
ポリフェノールを含有する食品 Download PDFInfo
- Publication number
- WO2005107498A1 WO2005107498A1 PCT/JP2005/008578 JP2005008578W WO2005107498A1 WO 2005107498 A1 WO2005107498 A1 WO 2005107498A1 JP 2005008578 W JP2005008578 W JP 2005008578W WO 2005107498 A1 WO2005107498 A1 WO 2005107498A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mass
- extract
- body fat
- effect
- pine bark
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Definitions
- the present invention relates to a food containing polyphenol having a body fat reducing effect and monolipoic acid or a derivative thereof.
- the present inventors have made intensive studies especially on combinations of components having a body fat reducing effect. As a result, the present inventors have found that a food containing a specific polyphenol and polylipoic acid has a more excellent effect of reducing body fat, leading to the present invention.
- the food of the present invention contains polyphenol having a body fat reducing effect and monolipoic acid or a derivative thereof.
- the food of the present invention further contains ubiquinone or a derivative thereof.
- the polyphenol having the effect of reducing body fat is a pine bark extract or a processed rose flower.
- body fat reducing effect refers to an effect of promoting fat consumption (decomposition), an effect of suppressing the accumulation of ingested fat as body fat, and an ingestion of absorbed fat into the body. As a result, it means the effect of reducing body fat.
- a food containing a polyphenol having a body fat reducing effect and herlipoic acid or a derivative thereof has a further excellent body fat reducing effect. It is considered that this effect was obtained by the effect of polyphenol having a body fat reducing effect on promoting lipolysis or suppressing lipid absorption, and the effect of ⁇ -lipoic acid on improving energy metabolism.
- Examples of the polyphenol having a body fat reducing effect used in the food of the present invention include flavonoids, tannins, chlorogenic acids, and ellagic acids.
- examples of the flavonoid include flavones, flavonols, flapanones, isoflavones, anthocyanidins, flavanols, catechins and the like.
- Tanyun includes condensed tannin, hydrolyzed tannin and the like.
- Such polyphenols have different physiological activities depending on their various structures.
- tannins, chlorogenic acids, ellagic acids, and isoflavones are preferably used, and condensed tannin and isoflavones are more preferably used.
- the present inventors have found that a pine bark extract and a processed flower of kuzuka, which are not conventionally known to have a body fat reducing effect, have a body fat reducing effect. Therefore, in the present invention, the pine bark extract and the processed vine can be used as a polyphenol having a body fat reducing effect.
- polyphenols having a body fat reducing effect may be used alone or in combination of two or more.
- Pine bark extract can be used as the polyphenol having a body fat reducing effect used in the food of the present invention.
- the raw materials for this pine bark extract are: French pine (Pinus Martima), Japanese larch, Japanese black pine, Japanese pine, Japanese pine, Japanese pine, Korean pine, Japanese pine, Japanese pine, Japanese pine, Japanese pine, Japanese white pine, Quebec in Canada Pine such as Aneda
- French pine Pieris Martima
- Japanese larch Japanese black pine
- Japanese pine Japanese pine
- Japanese pine Japanese pine
- Korean pine Japanese pine
- Japanese pine Japanese pine
- Japanese pine Japanese pine
- Japanese pine Japanese white pine
- Quebec in Canada Pine such as Aneda
- the bark of a plant belonging to the eye Of these, the bark of French pine (Pinus Martima) is preferably used.
- French pine is a marine pine that grows on part of the Atlantic coast of southern France.
- the bark of this French coastal pine contains proanthocyanidins, organic acids, and other bioactive ingredients.
- the pine bark extract used in the present invention contains, as one of the main components, proanthocyanidin, a kind of condensed tannin.
- Proanthocyanidins are a group of compounds consisting of polycondensates having a degree of polymerization of 2 or more and having flavan-13-ol and / or flavan-13,4-diol as a structural unit. It is a powerful antioxidant produced by plants, and is concentrated in plant leaves, bark, fruit bark and seeds. This proanthocyanidin is a substance that cannot be produced in the human body.
- the pine bark extract containing this proanthocyanidin has an excellent lipid-substituting and improving effect, that is, a body fat-reducing effect.
- a pine bark extract containing a large amount of a polycondensate having a low degree of polymerization is preferably used.
- the condensation polymer having a low polymerization degree a condensation polymer having a polymerization degree of 2 to 30 (2 to 30 mer) is preferable, and a condensation polymer having a polymerization degree of 2 to 10 (2 to 10 mer).
- a condensation polymer having a polymerization degree of 2 to 4 is further more preferable.
- Proanthocyanidins which are polycondensates (2-4 tetramers) with a degree of polymerization of 2-4, are particularly easy to be absorbed into the body, so they promote the excretion of cholesterol and promote the decomposition of neutral fats. It is thought that it can be more effectively obtained.
- the polymer having a degree of polymerization of 2 to 4 is referred to as oligomeric proanthocyanidin (hereinafter, referred to as “OPC”).
- pentamer or more proanthocyanidins are considered to have an effect of promoting excretion of cholesterol and inhibition of neutral fat absorption.
- pine bark extract polycondensates having a degree of polymerization of 2 to 4 (2 to 4 mer; ie, OPC) In a proportion of 15% by mass, preferably 20% by mass or more, more preferably 30% by mass, and pentamer or more proanthocyanidin in a proportion of 10% by mass or more, preferably 15% by mass or more. Extracts containing at least a percentage by mass are preferred.
- the pine bark extract contains OPC and pentamer or higher pentose anthocyanidins, thereby promoting cholesterol excretion, promoting the decomposition of triglycerides, and inhibiting the absorption of triglycerides. It is considered that a promoting effect is obtained. Such a synergistic action improves lipid metabolism in the body, and thus provides a body fat reducing effect.
- the pine bark extract may further contain catechins, and the catechins are preferably contained in a proportion of 5% by mass or more, more preferably 10% by mass or more.
- Catechins can be extracted together with proanthocyanidin (OPC) by the above extraction method.
- Catechins are a general term for polyhydroxyflapan-1-ol.
- catechins (+)-force techin (referred to as catechin in a narrow sense)
- (1) eppicatechin, (+)-gallo catechin (1) epigallocatechin, epigallocatechin gallate, epika techin gallate, Afferekin and the like are known.
- Catechins include carcinogenesis inhibitory action, arteriosclerosis preventive action, blood pressure rise inhibitory action, platelet aggregation inhibitory action, antiallergic action, antiviral action, antibacterial action, caries prevention action, bad breath prevention action, normal intestinal flora It is known to have an oxidizing effect, a scavenging effect of active oxygen and free radicals, and an antioxidant effect. Furthermore, catechins are known to have an anti-diabetic effect of suppressing an increase in blood sugar.
- Catechins are poorly water-soluble alone and have low physiological activity, but in the presence of OPC, they have the property of increasing water solubility and becoming active at the same time. Therefore, phytotechins work effectively when taken with OPC.
- the catechins are preferably contained in the pine bark extract in an amount of 5% by mass or more. More preferably, the pine bark extract containing 20% by mass or more of OPC and 10% by mass or more of pentamer orchid anthocyanidin preferably contains 5% by mass or more of catechins. For example, when the content of catechins in the pine bark extract is less than 5% by mass, force technics may be added so that the content is 5% by mass or more. Contains 5% by mass or more of force techin and 20 mass of OPC.
- a pine bark extract containing 10% by mass or more of proanthocyanin of at least / 0 and at least pentamer.
- the content of the specific component in the extract is a value based on the dry mass of the extract, and the same applies hereinafter unless otherwise specified.
- the pine bark extract used in the food of the present invention is obtained by extracting the pine bark with water or an organic solvent. If water is used, use warm or hot water. If an organic solvent is used, a solvent that is acceptable for the production of foods or drugs can be used. Examples of such an organic solvent, such as methanol, ethanol, 1-Purono ⁇ 0 Nonore, 2 Puropanonore, 1 Butano one Honoré, hexane 2 Butanonore, acetone, to, cyclohexane, propylene glycol, water ethanol , Hydrated propylene daricol, methyl ethyl ketone, glycerin, methyl acetate, ethyl acetate, 'ethyl ether, dichloromethane, edible oils, 1,1,1,2-tetrafluoroethane, and 1,1,2- Trichloroethene.
- an organic solvent such as methanol, ethanol, 1-Purono ⁇ 0 Nonore
- water and organic solvent may be used alone or in combination of two or more.
- water, ethanol, hydrous ethanol, and hydrous propylene dalicol are preferably used. From the viewpoint of safety when used in foods or pharmaceuticals, water, ethanol, and hydrous ethanol are more preferable, and extraction by heating is more preferable.
- Supercritical fluid extraction is a method in which a substance is extracted using a supercritical fluid, which is a fluid that has exceeded the critical point (critical temperature, critical pressure) of gas-liquid.
- a supercritical fluid which is a fluid that has exceeded the critical point (critical temperature, critical pressure) of gas-liquid.
- the supercritical fluid carbon dioxide, ethylene, propane, nitrous oxide (laughing gas) and the like are used, and dioxide carbon is preferably used.
- the supercritical fluid extraction method includes an extraction step of extracting a target component with a supercritical fluid, and a separation step of separating the target component from the supercritical fluid.
- a separation step any of extraction separation by pressure change, extraction separation by temperature change, and extraction separation using an adsorbent / absorbent may be performed.
- a supercritical fluid extraction method using an entrainer addition method may be used.
- this method for example, ethanol, propanol, n-hexane, acetone, toluene, other aliphatic lower alcohols, aliphatic hydrocarbons, aromatics
- hydrocarbons and ketones are added at about 2 to 20 W / V%, and this fluid is put into a supercritical fluid state to extract the target substance.
- the solubility of the target extract such as proanthocyanidins and catechins in the extraction solvent can be drastically increased, or the selectivity of separation can be enhanced.
- a bark extract can be obtained.
- the supercritical fluid extraction method can be operated at relatively low temperatures, so that it can be applied to substances that degrade and decompose at high temperatures; the advantage that no extraction fluid remains; and that the solvent can be recycled and used. There is an advantage that the solvent process can be omitted, and the process becomes simple.
- Extraction from pine bark may be performed by a liquid carbon dioxide batch method, a liquid carbon dioxide reflux method, a supercritical diacid carbon reflux method, or the like, in addition to the above method.
- Extraction from pine bark may be a combination of multiple extraction methods. Pine bark extracts of various compositions can be obtained by combining multiple extraction methods. It works.
- the pine bark extract obtained by the above extraction is subjected to ultrafiltration or
- the pine bark extract used in the food of the present invention is specifically prepared by the following method, but this is only an example and the present invention is not limited to this method.
- the step of adding 25 OmL of ethyl acetate to the crude extract, separating the mixture, and collecting the ethyl acetate layer is repeated five times.
- the collected ethyl acetate solutions are combined, directly added to 200 g of anhydrous sodium sulfate, and dehydrated. Then, the ethyl acetate solution is filtered, and the filtrate is concentrated under reduced pressure to 1/5 of the original volume. Pour the concentrated ethyl acetate solution into 2 L of chloroform and stir to collect the resulting precipitate by filtration.
- the step of dissolving the precipitate in 10 mL of ethyl acetate and then adding it again to a 1-L form of chloroform and precipitating for washing is repeated twice.
- this method for example, about 5 g of a pine bark extract containing 20% by mass or more of proanthocyanidins having a degree of polymerization of 2 to 4 and 5% by mass or more of phytotechins is obtained.
- Such a pine bark extract contains an organic acid and the like in addition to proanthocyanidin catechins, and therefore has an effect superior to the case where catechins and proanthocyanidins are simply used.
- a processed material of Kuzuka may be used as the polyphenol having an effect of reducing body fat used in the food of the present invention.
- This processed katsura flower is not particularly limited as long as it is a processed material of the flower part of a cassia plant belonging to the leguminous plant.
- Kuzuka includes flowers collected at the stage from bud to full bloom. Preferably, buds are used.
- the term "processed geisha” refers to a product obtained by subjecting geisha to at least one of a drying process, an inscription process, and an extraction process.
- the processed materials of geese include dried gems, crushed gems, dried gems (gem powder), and gems extract.
- the extract of kuzuhana includes an extract obtained by performing an extraction process on kuzuhana, crushed kuzuhana, dried kuzuhana, or kuzuhana powder.
- the shape of the Kuzuka extract is not limited, and may be a liquid, a paste, or a powder.
- the processed flower of kuzuhana used for the food of the present invention contains saponin, tributofan glycoside, and the like, in addition to flavonoids such as isoflavones, and can preferably contain isoflavones and saponin.
- the content of these components is not particularly limited.
- the amount of isoflavones in the processed material of rose flower is 3% by mass or more, more preferably 5% by mass to 90% by mass.
- Saponin is preferably at least 1% by mass, more preferably 2% to 50% by mass.
- a processed kudoka flower containing such isoflavones and saponin at a high content a kudoka flower extract is preferably used.
- the Kuzuka extract has the effect of preventing the accumulation of visceral fat and subcutaneous fat, and reduces visceral fat and subcutaneous fat. That is, the Kuzuka extract has a body fat reducing effect. As a result, it has an anti-obesity effect to reduce weight. Furthermore, it has a blood lipid improving effect.
- the dried product of katsuka is katsuka, preferably budding at the bud stage, dried by a method such as sun-drying or hot-air drying.
- the reaction is carried out until the water content becomes 10% by mass or less.
- Kuzuhana powder can be obtained by powdering the dried product of Kuzuhana. Powdering is performed by a method commonly used by those skilled in the art, for example, using a ball mill, a hammer mill, a roller mill, or the like.
- Kuzuhana powder can also be obtained by mining the collected Kuzuhana using a masco mouth whatsoever, slicer, commitrol, etc. to obtain a crushed Kuzuka flower, and drying this Kuzuka flower monument .
- Kuzuka extract is prepared by adding a solvent to Kuzuka collection, Kuzuka crushed product, Kuzuka dried product, or Kuzuka powder (hereinafter sometimes simply referred to as “extraction raw material”). It is obtained by performing extraction by heating and collecting the extract by centrifugation or filtration.
- Examples of the solvent used for extracting the Kuzuhana extract from the extraction raw material include water, an organic solvent, a water-containing organic solvent, and the like, most preferably ethanol, as in the pine bark extract described above.
- the extraction temperature is not particularly limited as long as it is lower than the boiling point of the solvent used.
- the extraction temperature varies depending on the solvent used, but is generally 4 ° C to 130 ° C in consideration of the decomposition of the active ingredient. Preferably it is 50 ° C to 130 ° C, more preferably 70 ° C to 100 ° C.
- a heating extraction method such as heating and refluxing, a supercritical extraction method, and the like can be employed.
- pressurization may be performed.
- the extraction time may be any time as long as the soluble component is sufficiently extracted from the extraction raw material, and may be appropriately set according to the extraction temperature and the like. Preferably 30 minutes to 48 o'clock Between. For example, if the extraction temperature is less than 50 ° C., it can be extracted for 6 to 48 hours, and if it is 50 ° C. or more, it can be extracted for 30 minutes to 24 hours.
- the obtained extract is concentrated, if necessary, by a method used by those skilled in the art, such as concentration under reduced pressure, freeze-drying, etc., to give a liquid, paste-like, or powdery powder, whereby a Kuzuka extract can be obtained.
- the powdered Kuzuka extract may be referred to as extract powder.
- this extract can be combined with synthetic adsorbents (Diaion HP20, Sephavis SP825, Amberlite XAD4, MCImage 1 CHP20P, etc.) and dextran resin (Sephadex LH-20, etc.) ) Can be used for further purification to obtain kuzuhana extract with high concentrations of flavonoids and saponins.
- synthetic adsorbents Diaion HP20, Sephavis SP825, Amberlite XAD4, MCImage 1 CHP20P, etc.
- dextran resin Sephadex LH-20, etc.
- the lipoic acid used in the food of the present invention is also called thioctic acid and is a substance widely distributed in the animal and plant kingdoms. Lipoic acid has been shown to act as a coenzyme in vivo in biochemical reactions in the Krebs cycle, particularly in the decarboxylation of pyruvate and other keto acids.
- the ⁇ - lipoic acid and derivatives thereof used in the food of the present invention for example, alpha - lipoic acid; alpha - sodium salt of lipoic acid, alkali metal salts such as potassium salts; the ⁇ - lipoic acid Amin salt or Anmoniumu Salts; alkyl or alkenyl esters of ⁇ -lipoic acid; amides such as lipoamide and lipoyl lysine; and dihydrolipoic acid, dihydrolipoic acid alkyl or alkenyl ester, amides and the like as reducing agents.
- alpha - lipoic acid alpha - sodium salt of lipoic acid, alkali metal salts such as potassium salts
- the ⁇ - lipoic acid Amin salt or Anmoniumu Salts alkyl or alkenyl esters of ⁇ -lipoic acid
- amides such as lipoamide and lipoyl lysine
- the food of the present invention preferably further contains ubiquinone or a derivative thereof.
- Ubiquinone is a substance called Coenzym Q10 (hereinafter sometimes referred to as CoQIO) or ubidecarenone.
- CoQIO Coenzym Q10
- ubiquinone is a substance that is significantly involved in the production of ATP (adenosine triphosphate), which is a source of energy in the inner mitochondrial membrane in vivo.
- CoQIO has an antioxidant effect, but it has been found that it is converted to CoQIO force ubiquinol in vivo to exhibit antioxidant activity. It is known that the concentration of such CoQIO in a living body decreases with aging.
- CoQIO has been ingested as food for the purpose of preventing aging, and can be obtained as a food material or cosmetic material. Therefore, it is possible to use such a commercially available product as a raw material of the food of the present invention.
- Examples of the derivatives of ubiquinone include compounds having improved water solubility of CoQIO, phosphate compounds of CoQ10, and the like.
- ubiquinone or its derivatives may be used alone or in combination of two or more.
- the food of the present invention may contain functional components other than the above components.
- functional components include royal jelly, propolis, vitamins (A, C, D, E, K, folate, pantothenic acid, biotin, derivatives thereof, etc.), and minerals (iron, magnesium, calcium, etc.).
- components that promote sugar and lipid metabolism are preferably used.
- these components include, for example, B vitamins and their derivatives, catechins, isomerized linoleic acid, caffeine, capsaicin, carnitine, saponin, soy peptide, amino acids, and branched amino acids (parin, isoleucine, leucine, etc.) And arginine, phosphatidylcholine, arylsulfide compounds, phorenoscholine, benoregenin, kenorecetin, astinolevin, hydroxycunic acid, salts thereof, and plant and animal-derived extracts containing these.
- the food of the present invention contains a polyphenol having an effect of reducing body fat, such as the above-mentioned pine bark extract and processed rosewood, and ⁇ -lipoic acid or a derivative thereof, and preferably further contains ubiquinone or a derivative thereof. contains. If necessary, it may contain other functional ingredients, nutritional ingredients, additives and the like. Specifically, using these components, processing usually performed by those skilled in the art is performed to prepare various shapes. INDUSTRIAL APPLICABILITY The food of the present invention effectively suppresses the accumulation of body fat due to calorie intake and, as a result, reduces body fat, and thus can be used as a body fat reducing agent (body fat accumulation inhibitor).
- body fat accumulation inhibitor body fat accumulation inhibitor
- the food processing method of the present invention includes, for example, tablets, pills and the like by adding an excipient to polyphenol having an action of reducing body fat and ⁇ -lipoic acid or a derivative thereof.
- the powder may be formed into a powder form, or the powder may be formed without being formed into another form.
- Other dosage forms include capsules such as hard capsules and soft capsules, powders, granules, liquids, and pastes. It can also be processed into tea bags, candy, etc.
- the method of ingesting the food of the present invention is not particularly limited.
- the food of the present invention may be eaten and consumed as it is, or may be dissolved in water, hot water, milk, or the like, depending on its shape or taste, or may be drunk with leached components.
- the food of the present invention contains polyphenol having a body fat reducing action and herlipoic acid or a derivative thereof at an arbitrary ratio. It varies depending on the content of polyphenol or the content of the polyphenol in the extract, the dosage form, etc. In general, the polyphenol having a body fat reducing action is contained in the food of the present invention in an amount of 0.0001% by mass. It is contained at a ratio of 5050% by mass.
- the pine bark extract when a pine bark extract is used, the pine bark extract is contained in the food in an amount of 0.001% by mass to 50% by mass. / 0 , preferably 0.001% by mass to 40% by mass.
- the processed vocal flower is contained in the food at a rate of 0.0001% by mass to 80% by mass, preferably 0.0005% by mass to 50% by mass.
- the daily intake of the food of the present invention is 0.0005 g or more, preferably 0.000 lg or more, more preferably 0.0005 g or more, as a polyphenol having a body fat reducing effect. Is greater than 0.005 g and most preferably greater than 0.001 lg. Furthermore, the intake of the pine bark extract and the processed material of moss flower containing polyphenol having the effect of reducing body fat is 0.001 g or more, preferably 0.001 g or more.
- the daily intake is 2.0 g or less, preferably 1.0 g or less, more preferably 0.6 g or less, as the intake of polyphenol having a body fat reducing effect.
- a pine bark extract containing a polyphenol having an effect of reducing body fat and a processed vocal flower a pine bark extract containing a polyphenol having an effect of reducing body fat and a processed vocal flower
- the processed material of katsuka is 3 g or less, preferably lg or less, as the intake of the katsuka extract.
- the processed material of geisha is dried geisha, it is 30 g or less, preferably 10 g or less.
- ⁇ -lipoic acid and its derivatives contents of ⁇ -lipoic acid and its derivatives, and ubiquinone and its derivatives.
- contents of ⁇ -lipoic acid and its derivatives 5 parts by mass to 150 parts by mass, preferably 5 parts by mass to 100 parts by mass with respect to 100 parts by mass of the dry mass of polyphenol having a body fat reducing effect.
- the content of ubiquinone or a derivative thereof is 5 parts by mass to 2000 parts by mass, preferably 10 parts by mass to 100 parts by mass.
- -lipoic acid and its derivative are from 5 parts by mass to 16500 parts by mass. Parts by mass, preferably 5 parts by mass to 110 parts by mass.
- the amount of ubiquinone and a derivative thereof is 5 parts by mass to 220 parts by mass, preferably 10 parts by mass to 110 parts by mass.
- the blood is again massaged from the orbit, and the triglyceride level in the blood is measured using a triglyceride measuring kit (Wako Pure Chemical Industries, Ltd.). It was measured. The measurement results were calculated by dividing the measured value before administration by 1 and the measured value at each time after administration as a relative value. Table 1 shows the results.
- the test group to which pine bark extract was administered together with cottonseed oil showed an increase in triglyceride in blood associated with cottonseed oil administration compared to the control group to which cottonseed oil alone was administered. It has been found that can be suppressed. That is, it was found that the pine bark extract that can be used in the food of the present invention has a lipid absorption inhibitory action and suppresses an increase in neutral fat in blood.
- Test feed A was prepared by adding the above processed processed material of kuzuhana at 5% by mass to this control feed.
- test feed A for the rats divided into the above three groups, one group contained test feed A
- Test group A test feed B (test group B) in the other group, The remaining groups were fed a control diet (control group).
- test group A which consumed test feed A containing the processed material of kuzuhana
- test group B which consumed test feed B containing the soybean extract
- the weight value was small. Therefore, it was found that the test feed A, that is, the feed containing the processed material of varieties of varieties, had an effect of reducing the covered fat compared to the test feed B and the control feed.
- test group 1 Twenty-five 7-week-old female ICR mice (CLEA Japan) were acclimated to a basic diet (MF diet, Oriental Yeast Co., Ltd.) for one week. Then Each group was divided into five groups so that the average weight was almost the same. Next, a feed was prepared by adding 40% by mass of tallow and 9% by mass of granulated sugar to the basic feed (a control feed). This control diet, was added at a rate of the pine bark extract 3 mass% and alpha _ lipoic acid 0.1 wt%, to prepare a test feed 1. One group was allowed to freely ingest test feed 1 (referred to as test group 1).
- test feed 2 was prepared in the same manner as the test feed 1, except that the pine bark extract used in the test feed 1 was replaced by a konjac extract.
- One group was allowed to freely consume test feed 2 (referred to as test group 2).
- 1 mass of CoQ IO was added to the test feed 1 above.
- Test feed 3 added at a ratio of / 0 was prepared.
- One group was allowed to freely consume test feed 3 (referred to as test group 3).
- a comparative feed was prepared in the same manner as the test feed 1 except that the pine bark extract was not contained.
- One group was allowed to freely consume the comparative feed (compared to the comparative group). The other group had free access to the control diet (control group).
- test groups 1 to 3 that consumed the test diets 1 to 3 containing the pine bark extract or the rose flower extract and ⁇ -lipoic acid fed the comparative diet and the control family.
- the amount of subcutaneous fat was smaller than in the control group and the control group. That is, it was found that test feeds 1 to 3 had an excellent body fat reducing effect.
- test group 3 which received test feed 3 containing pine bark extract, ⁇ -lipoic acid, and CoQ10 showed particularly excellent effects.
- the food of the present invention contains a polyphenol having a body fat reducing effect, in particular, a polyphenol derived from a pine bark extract or a processed rose flower and ⁇ -lipoic acid or a derivative thereof. Has a reduction effect. Therefore, the book
- the food of the invention is particularly useful as a health food and a body fat reducing agent. It is considered that this effect was obtained by the effect of polyphenol having a body fat reducing effect on promoting lipid degradation and promoting lipid absorption, and the effect of 0; -lipoic acid on improving energy metabolism.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Mycology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Claims
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004140142 | 2004-05-10 | ||
JP2004-140142 | 2004-05-10 | ||
JP2004-174396 | 2004-06-11 | ||
JP2004174396 | 2004-06-11 | ||
JP2004216923 | 2004-07-26 | ||
JP2004-216923 | 2004-07-26 | ||
JP2005-044825 | 2005-02-21 | ||
JP2005044825A JP2007289001A (ja) | 2004-05-10 | 2005-02-21 | ポリフェノールを含有する食品 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005107498A1 true WO2005107498A1 (ja) | 2005-11-17 |
Family
ID=35319970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2005/008578 WO2005107498A1 (ja) | 2004-05-10 | 2005-04-28 | ポリフェノールを含有する食品 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP2007289001A (ja) |
WO (1) | WO2005107498A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5305500B2 (ja) * | 2008-01-30 | 2013-10-02 | 株式会社盛光 | リパーゼ阻害剤及びそれを含有する組成物 |
WO2012147619A1 (ja) * | 2011-04-27 | 2012-11-01 | キッコーマン株式会社 | 血糖値上昇抑制剤 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002071874A2 (en) * | 2001-03-09 | 2002-09-19 | Societe Des Produits Nestle S.A. | Composition improving age-related physiological deficits and increasing longevity |
JP2002534445A (ja) * | 1999-01-11 | 2002-10-15 | イーストマン ケミカル カンパニー | 血中コレステロール及び/又は血中トリグリセリドの低下方法 |
JP2003342185A (ja) * | 2002-05-25 | 2003-12-03 | Bhn Kk | リパーゼ活性阻害剤 |
JP2004049135A (ja) * | 2002-07-22 | 2004-02-19 | Toyo Shinyaku:Kk | 健康食品 |
-
2005
- 2005-02-21 JP JP2005044825A patent/JP2007289001A/ja active Pending
- 2005-04-28 WO PCT/JP2005/008578 patent/WO2005107498A1/ja active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002534445A (ja) * | 1999-01-11 | 2002-10-15 | イーストマン ケミカル カンパニー | 血中コレステロール及び/又は血中トリグリセリドの低下方法 |
WO2002071874A2 (en) * | 2001-03-09 | 2002-09-19 | Societe Des Produits Nestle S.A. | Composition improving age-related physiological deficits and increasing longevity |
JP2003342185A (ja) * | 2002-05-25 | 2003-12-03 | Bhn Kk | リパーゼ活性阻害剤 |
JP2004049135A (ja) * | 2002-07-22 | 2004-02-19 | Toyo Shinyaku:Kk | 健康食品 |
Also Published As
Publication number | Publication date |
---|---|
JP2007289001A (ja) | 2007-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2006298857A (ja) | 育毛剤および育毛用キット | |
JP2003325135A (ja) | 健康食品 | |
AU2006347125B2 (en) | Antioxidant composition containing component originating in the bark of tree belonging to the genus Acacia | |
JP2006016390A (ja) | プロアントシアニジン含有組成物 | |
JP4879741B2 (ja) | 体脂肪低減剤 | |
JP2004123707A (ja) | 血流改善組成物 | |
JP2003146898A (ja) | 高脂血症改善剤 | |
JP4468837B2 (ja) | 抗肥満剤 | |
JP2005097273A (ja) | 運動能力向上組成物 | |
WO2005107498A1 (ja) | ポリフェノールを含有する食品 | |
JP4400712B2 (ja) | 抗酸化能増強食品 | |
JP4648309B2 (ja) | プロアントシアニジン水可溶性結合体およびそれを含有する組成物 | |
JP4754190B2 (ja) | アルコール代謝向上剤 | |
JP2004210675A (ja) | 骨量改善組成物 | |
US20050176654A1 (en) | Composition for regulating bone metabolism | |
JP2006022082A (ja) | 脂質代謝改善剤 | |
JP2007054001A (ja) | 苦味または渋味を有する食品原料を含有する食品 | |
JP4700313B2 (ja) | プロアントシアニジン及びスフィンゴ脂質を含む組成物 | |
JP2005023032A (ja) | 動脈硬化予防剤 | |
WO2006001112A1 (ja) | 育毛剤 | |
EP1688140A1 (en) | Lipometabolism improver containing pine bark extract | |
JP2006111617A (ja) | イチョウ葉抽出物含有組成物 | |
WO2005107783A1 (ja) | 松樹皮抽出物を含有する食品 | |
JP4847712B2 (ja) | アカシア属樹皮由来物を含有する抗酸化組成物 | |
US20060105096A1 (en) | Food composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |